Treating CLL cells with macitentan for 4 hours and then stimulating them with CXCL12 for 10 minutes, phosphorylation of AKT was significantly decreased (Figure 5C, n=4, P<0.05). Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.